GLOBAL COVID-19 DIAGNOSTICS MARKET SIZE TO REACH USD 7.4 BILLION BY 2026

COVID-19 Diagnostics Market Size, Share, Trends Analysis Report by Products (Consumables and Analyzers/Instruments), End-users (Laboratories, Hospitals, Ambulatory Care Settings, and Research Institutes), Test (PCR, Antigen, and Antibody), Technology (Molecular and Immunology), and Geography (APAC, North America, Europe, Latin America, and the Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Market Trends, Competitive Market Share & Forecast, 2021-2026

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

283 Pages

78 Tables

132 Charts

5 Regions

25 Countries

55 Companies

5 Market Segment

GLOBAL COVID-19 DIAGNOSTICS MARKET REPORT SCOPE

Report Attribute Details
Market Size (Revenue) USD 7.4 BILLION (2026)
CAGR (9)% (2021–2026)
Base Year 2020
Forecast Year 2021-2026
Market Segments Products (Consumables and analyzers/Instruments), End-users (Laboratories, Hospitals, Ambulatory Care Settings, and Research Institutes), Test (PCR, Antigen, and Antibody), Technology (Molecular and Immunology)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, Russia, China, Japan, South Korea, Australia, India, Indonesia, Philippines, Brazil, Peru, Mexico, Argentina, Colombia, Chile, Turkey, South Africa, Iran, and Saudi Arabia

INDUSTRY INSIGHTS

The global COVID-19 diagnostics market size is valued at USD 13 billion in 2020 and is expected to reach USD 7.4 billion by 2026. The RT-PCR testing segment constituted over 75% of the global COVID test market share. The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world.  As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market. 

SNIPPETS

  • The consumables segment is expected to reach close to USD 6 billion by 2026 on account of the increased usage of a wide array of reagents and COVID-19 test kits.
  • The PCR segment is projected to touch revenue of over USD6 billion by 2026 as PCR tests are considered quick, specific, and accurate, and less prone to contamination.
  • In terms of revenue, the diagnostic segment is likely to dominate the COVID-19 diagnostics market. Diagnostic labs have an extremely high capacity to handle many samples and deliver results in a short duration.
  • The Asia Pacific COVID-19 test market is expected to observe high revenue during the forecast period because of the high prevalence of the coronavirus infection.

GLOBAL COVID-19 DIAGNOSTICS MARKET SEGMENTATION

 This research report includes a detailed segmentation by

  1. Product
  2. End-users
  3. Test
  4. Technology
  5. Geography

INSIGHTS BY PRODUCT

In 2020, the consumables segment constituted over 74% of the global COVID-19 diagnostics market share. The demand for consumables, including biomarkers and reagents, including substrates, enzymes, electrolytes, specific proteins, lipids, and point-of-care (POC) test kits, is growing as they obtain quick and accurate results for diagnosing diseases, including COVID-19. The need to perform rapid testing to detect coronavirus spread across the world is driving the demand for consumables.

The analyzers/instruments COVID-19 test kits segment accounted for over 25% of the global COVID-19 testing market. This segment is growing at a relatively slower pace than consumables as it is capital intensive, and purchasing decisions for the same depends on financial resources and budget allocations. The demand for PCR analyzers is expected to grow at a steady rate, with vendors introducing diverse innovative and next-generation analyzers. 

INSIGHTS BY TEST

As RT-PCR testing is considered exceptionally reliable, the segment constituted over 75% of the global COVID diagnostics market share. The market is witnessing an increasing uptake of PCR testing to deliver a reliable diagnosis in quick succession. Currently, the reverse transcription-polymerase chain reaction (RT-PCR Test) is a standard for diagnosing COVID-19. With the WHO recommending PCR testing as one of the reliable methods for COVID-19 test procedures, countries such as the US, Brazil, Russia, India, Germany, Italy, and Spain drive the demand for PCR kits the virus highly infects these regions. Antigen and antibody testing accounted for a small share of the global COVID-19 diagnostics market. These tests are considered an important factor in mass screening. However, due to a lack of specificity and sensitivity, these tests were not initially used in several countries. As the COVID-19 pandemic continues, vendors came up with advanced antibody and antigen tests, driving the COVID-19 testing market growth. 

INSIGHTS BY TECHNOLOGY

The failure of several rapid diagnostics testing kits to detect the presence of the COVID-19 virus in several countries has led to the development of molecular-based-PCR COVID testing. The share of molecular diagnostic test makers has increased drastically, with the WHO declaring RT-PCR as the standard test for COVID-19 diagnosis. This trend is followed in several developed, developing, and underdeveloped countries, thereby generating a high demand for molecular diagnostic testing. The immunoassay segment accounted for over 24% of the global market share in 2020. These tests are conducted in real-time on those with maximum exposure to the COVID-19 virus, especially healthcare professionals and medical practitioners.

Immunoassay tests received a setback in most countries due to their limited specificity and sensitivity. They produced several false positive and false negative results, which made people look for alternative tests. However, vendors came up with high sensitivity and specific immunoassay tests with superior results.

INSIGHTS BY END-USERS

In most countries, diagnostic laboratories, which include standard and public health organizations, have played a significant role in detecting COVID-19. The demand for standalone laboratories is growing gradually owing to the prevalence of pandemic, epidemic conditions, or the outbreak of unexpected infectious diseases, requiring immediate diagnosis of the diseases for a large population in a shorter time. The end-user hospitals segment has played a major role in COVID-19 testing since its outbreak. A majority of hospitals have their own in-house laboratories to conduct COVID-19 tests, which help them to admit and monitor COVID-19 patients. Hence the segment is witnessing a high demand for COVID-19 testing kits. The demand for COVID-19 diagnostic kits from ambulatory care settings increased in developed countries as these settings accommodated several asymptomatic patients.

INSIGHTS BY GEOGRAPHY

APAC emerged as the largest COVID-19 diagnostics market and is likely to retain its position during the forecast year due to the widespread COVID-19 infection in the population. Several countries in the region, especially India, where the number of people infected with coronavirus stood at 8.5 million in October 2020, are likely to increase mass COVID-19 testing, thereby increasing the demand. The presence of a large population, poor living standards, and inadequate medical infrastructure are the major factors responsible for the infection's high prevalence. However, increased mass COVID-19 testing initiatives and high investments in public healthcare services are likely to favor the COVID-19 testing market. China, Japan, India, South Korea, and Australia are the major revenue contributors to the APAC COVID-19 diagnostics market. Several countries preferred using PCR-based COVID testing due to their higher accuracy than serological tests. Australia and New Zealand have increased their COVID-19 testing capacities to reduce the impact of the disease.

In 2020, North America accounted for a share of 25% of the global COVID-19 diagnostics market. The US, with developed healthcare infrastructure, is still struggling to contain the spread of the virus. This region has recorded the second-highest tests after APAC. The countries in the region are focusing on the high use of antibody tests and antigen tests. The US government plans to distribute 150 million rapid COVID-19 test kits from Abbott laboratories. 

INSIGHTS BY VENDORS

The global coronavirus diagnostics market is highly dynamic with the presence of several global, regional, and local company profiles, offering a diverse range of analyzers, test kits, assays, and reagents to perform COVID-19 tests. Abbott, BD, Danaher, F. Hoffmann-La Roche, Siemens Healthineers, and Thermo Fisher Scientific are the major player in the diagnostics market. Global market players focus on developing innovative products, producing COVID-19 vaccines, and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio.

The COVID-19 diagnostics market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

By Product

  • Consumables
  • Analyzers/Instruments

By Test 

  • PCR
  • Antigen
  • Antibody

By Technology  

  • Molecular
  • Immunology

By End-user

  • Laboratories
  • Hospitals
  • Ambulatory Care Settings
  • Research Institutes 

By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
    • Indonesia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Peru
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Turkey
    • Iran

Frequently Asked Questions

The global COVID-19 diagnostics market size to reach USD 7.4 billion in 2026.
As RT-PCR testing is considered exceptionally reliable, the segment constituted over 75% of the global COVID diagnostics market share.
Establishing strategic acquisitions, investing extensively in R&D and product development, and commercializing innovative analyzers, POC devices, rapid test kits, and consumables are key perspectives that vendors can leverage.
The global COVID-19 diagnostics market by tests is segmented into the PCR, antibody (serology) tests, and antigen Tests (Rapid diagnostics tests). PCR accounted for a major share of the COVID-19 testing market.
Abbott, BD, Danaher, F. Hoffmann-La Roche, Siemens Healthineers, and Thermo Fisher Scientific are the major player in the diagnostics market.
Download Free Sample

The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2020–2026. 

The following factors are likely to contribute to the growth of the COVID-19 diagnostics market during the forecast period:

  • Increased Demand for Mass Testing
  • Demand for Molecular Diagnostics due to Covid-19 Pandemic
  • Unavailability of Specific Medicines/ Vaccines

Base Year:                  2020

Forecast Year:           2021–2026

The study considers the present scenario of the COVID-19 diagnostics market and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Siemens Healthineers
  • Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Danaher
  • BD

Other Prominent Vendors

  • Abingdon Health
    • Business Overview
    • Product Offerings
  • ACCESS BIO
  • Assure Tech. (Hangzhou)
  • Autobio Diagnostics
  • Advaite
  • Babson Diagnostics
  • Beijing Wantai Biological
  • Biomerica
  • bioMérieux
  • Biopanda Reagents
  • Biocerna
  • Biocan Diagnostics
  • BioMedomics
  • Clinical Reference Laboratory
  • Cellex
  • The Center for Chest Diseases and Prevention (CDC)
  • CTK Biotech
  • DiaSorin
  • Diazyme Laboratories
  • Erba Mannheim
  • Edinburgh Genetics
  • Eurofins Scientific
  • GenScript
  • Healgen Scientific
  • Hangzhou AllTest Biotech
  • Hangzhou Biotest Biotech
  • Jiangsu Well Biotech
  • Kabla Diagnostics
  • Luminex
  • Meridian Bioscience
  • Megna Health
  • Microgen
  • MP Biomedicals
  • Nova Tech Immunodiagnostica
  • NOWDiagnostics
  • Quotient
  • QIAGEN
  • Quidel
  • Sekisui Diagnostics
  • Sinocare
  • SureScreen Diagnostics
  • Salofy Oy
  • Shenzhen New Industries Biomedical Engineering (SNIBE)
  • Sysmex
  • SEASUN BIOMATERIALS
  • Vibrant America
  • Warrior Diagnostics
  • Xiamen Biotime Biotechnology
  • Zuhai Livzon Diagnostic

By Product

  • Consumables
  • Analyzers/Instruments

By Test 

  • PCR
  • Antigen
  • Antibody

By Technology  

  • Molecular
  • Immunology

By End-user

  • Laboratories
  • Hospitals
  • Ambulatory Care Settings
  • Research Institutes 

By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
    • Indonesia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Peru
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Turkey
    • Iran

 

1              Research Methodology

2              Research Objectives

3              Research Process

 

4              Scope & Coverage

4.1          Market Definition

4.1.1      Inclusions

4.1.2      Exclusions

4.2          Base Year

4.3          Scope Of The Study

4.3.1      Market Segmentation by Geography

 

5              Report Assumptions & Caveats

5.1          Key Caveats

5.2          Currency Conversion

5.3          Market Derivation

 

6              Market at a Glance

7              Introduction

7.1          Overview

7.2          COVID-19 Impact on Global Supply Chain of COVID-19 Diagnostics

7.2.1      Overview

7.2.2      Bridging Supply-Demand Gap of COVID-19 Diagnostics

 

8              Market Opportunities & Trends

8.1          Increase In Demand For Mass Testing

8.2          Raise Of Second Wave Of Covid-19

8.3          High Demand For Molecular Diagnostics

 

9              Market Growth Enablers

9.1          Unavailability Of Specific Medicines/Vaccines

9.2          More Product Launches Combined With EUA

9.3          Widespread Practice Of Testng To Control COVID-19

 

10           Market Restraints

10.1        Challenges In Testing Covid-19 In Developing Countries

10.2        Preventive Measures And  Fastrack Of Vaccine Development

10.3        Increase In Proportion Of False Positive And Negative Tests

 

11           Market Landscape

11.1        Market Overview

11.2        Market Size & Forecast

11.2.1    Product

11.2.2    Test

11.2.3    Technology

11.2.4    End-User

11.2.5    Geography

11.3        Five Forces Analysis

11.3.1    Threat of New Entrants

11.3.2    Bargaining Power of Suppliers

11.3.3    Bargaining Power of Buyers

11.3.4    Threat of Substitutes

11.3.5    Competitive Rivalry

 

12           Product

12.1        Market Snapshot & Growth Engine

12.2        Market Overview

12.3        Consumables

12.3.1    Market Overview

12.3.2    Market Size & Forecast

12.3.3    Consumables: Segmentation By Geography

12.4        Analyzers & Software

12.4.1    Market Overview

12.4.2    Market Size & Forecast

12.4.3    Analyzers: Segmentation By Geography

 

13           Test

13.1        Market Snapshot & Growth Engine

13.2        Market Overview

13.3        PCR

13.3.1    Market Overview

13.3.2    Market Size & Forecast

13.3.3    PCR: Segmentation By Geography

13.4        Antigen Test

13.4.1    Market Overview

13.4.2    Market Size & Forecast

13.4.3    Antigen Test: Segmentation By Geography

13.5        Antibody Testing

13.5.1    Market Overview

13.5.2    Market Size & Forecast

13.5.3    Antibody Testing: Segmentation By Geography

 

14           Technology

14.1        Market Snapshot & Growth Engine

14.2        Market Overview

14.3        Molecular

14.3.1    Market Overview

14.3.2    Market Size & Forecast

14.3.3    Molecular Diagnostics: Segmentation By Geography

14.4        Immunoassay

14.4.1    Market Overview

14.4.2    Market Size & Forecast

14.4.3    Immuno Diagnostics: Segmentation By Geography

 

15           End-User

15.1        Market Snapshot & Growth Engine

15.2        Market Overview

15.3        Diagnostic Laboratories

15.3.1    Market Overview

15.3.2    Market Size & Forecast

15.4        Hospitals

15.4.1    Market Overview

15.4.2    Market Size & Forecast

15.5        Ambulatory Care Settings

15.5.1    Market Overview

15.5.2    Market Size & Forecast

15.6        Research Institutes

15.6.1    Market Overview

15.6.2    Market Size & Forecast

 

16           Geography

16.1        Market Snapshot & Growth Engine

16.2        Geographic Overview

 

17           APAC

17.1        Market Overview

17.2        Market Size & Forecast

17.3        Key Countries

17.3.1    China: Market Size & Forecast

17.3.2    India: Market Size & Forecast

17.3.3    Japan: Market Size & Forecast

17.3.4    South Korea: Market Size & Forecast

17.3.5    Australia: Market Size & Forecast

17.3.6    Indonesia: Market Size & Forecast

17.3.7    Philippines: Market Size & Forecast

 

18           North America

18.1        Market Overview

18.2        Market Size & Forecast

18.3        Key Countries

18.3.1    US: Market Size & Forecast

18.3.2    Canada: Market Size & Forecast

 

19           Europe

19.1        Market Overview

19.2        Market Size & Forecast

19.3        Key Countries

19.3.1    Russia: Market Size & Forecast

19.3.2    UK: Market Size & Forecast

19.3.3    Germany: Market Size & Forecast

19.3.4    Spain: Market Size & Forecast

19.3.5    France: Market Size & Forecast

19.3.6    Italy: Market Size & Forecast

 

20           Middle East And Africa

20.1        Market Overview

20.2        Market Size & Forecast

20.3        Key Countries

20.3.1    Turkey: Market Size & Forecast

20.3.2    Saudi Arabia: Market Size & Forecast

20.3.3    South Africa: Market Size & Forecast

20.3.4    Iran: Market Size & Forecast

 

21           Latin America

21.1        Market Overview

21.2        Market Size & Forecast

21.3        Key Countries

21.3.1    Brazil: Market Size & Forecast

21.3.2    Peru: Market Size & Forecast

21.3.3    Columbia: Market Size & Forecast

21.3.4    Chile: Market Size & Forecast

21.3.5    Mexico: Market Size & Forecast

21.3.6    Argentina: Market Size & Forecast

 

22           Competitive Landscape

22.1        Competition Overview

22.1.1    Competitive Scenario

22.2        Vendors Focus on Accelerating Production & Streamlining Supply Chain of COVID-19 Diagnostics

22.2.1    WHO’s Efforts/Initiatives to Increase Supply of COVID-19 Tests for LMICs

22.3        Market Share Analysis

22.3.1    Abbott

22.3.2    Siemens Healthineers

22.3.3    F. Hoffmann-La Roche

22.3.4    Thermo Fisher Scientific

22.3.5    Danaher

22.3.6    BD

 

23           Key Company Profiles

23.1        Abbott

23.1.1    Business Overview

23.1.2    Product Offerings

23.1.3    Key Strategies

23.1.4    Key Strengths

23.1.5    Key Opportunities

23.2        Siemens Healthineers

23.2.1    Business Overview

23.2.2    Product Offerings

23.2.3    Key Strategies

23.2.4    Key Strengths

23.2.5    Key Opportunities

23.3        F. Hoffmann-La Roche

23.3.1    Business Overview

23.3.2    Product Offerings

23.3.3    Key Strategies

23.3.4    Key Strengths

23.3.5    Key Opportunities

23.4        Thermo Fisher Scientific

23.4.1    Business Overview

23.4.2    Product Offerings

23.4.3    Key Strategies

23.4.4    Key Strengths

23.4.5    Key Opportunities

23.5        Danaher

23.5.1    Business Overview

23.5.2    Product Offerings

23.5.3    Key Strategies

23.5.4    Key Strengths

23.5.5    Key Opportunities

23.6        BD

23.6.1    Business Overview

23.6.2    Product Offerings

23.6.3    Key Strategies

23.6.4    Key Strengths

23.6.5    Key Opportunities

 

24           Other Prominent Vendors

24.1        Abingdon Health

24.1.1    Business Overview

24.1.2    Product Offerings

24.2        ACCESS BIO

24.2.1    Business Overview

24.2.2    Product Offerings

24.3        Assure Tech. (Hangzhou)

24.3.1    Business Overview

24.3.2    Product Offerings

24.4        Autobio

24.4.1    Business Overview

24.4.2    Product Offerings

24.5        Advaite

24.5.1    Business Overview

24.5.2    Product Offerings

24.6        Babson Diagnostics

24.6.1    Business Overview

24.6.2    Product Offerings

24.7        Beijing Wantai Biological

24.7.1    Business Overview

24.7.2    Product Offerings

24.8        Biomerica

24.8.1    Business Overview

24.8.2    Product Offerings

24.9        bioMérieux

24.9.1    Business Overview

24.9.2    Product Offerings

24.10     Biopanda Reagents

24.10.1  Business Overview

24.10.2  Product Offerings

24.11     Biocerna

24.11.1  Business Overview

24.11.2  Product Offerings

24.12     Biocan Diagnostics

24.12.1  Business Overview

24.12.2  Product Offerings

24.13     BioMedomics

24.13.1  Business Overview

24.13.2  Product Offerings

24.14     Clinical Reference Laboratory

24.14.1  Business Overview

24.14.2  Product Offerings

24.15     Cellex

24.15.1  Business Overview

24.15.2  Product Offerings

24.16     The Centers for Disease Control and Prevention (CDC)

24.16.1  Business Overview

24.16.2  Product Offerings

24.17     CTK Biotech

24.17.1  Business Overview

24.17.2  Product Offerings

24.18     DiaSorin

24.18.1  Business Overview

24.18.2  Product Offerings

24.19     Diazyme Laboratories

24.19.1  Business Overview

24.19.2  Product Offerings

24.20     Erba Mannheim

24.20.1  Business Overview

24.20.2  Product Offerings

24.21     Edinburgh Genetics

24.21.1  Business Overview

24.21.2  Product Offerings

24.22     Eurofins Scientific

24.22.1  Business Overview

24.22.2  Product Offerings

24.23     GenScript

24.23.1  Business Overview

24.23.2  Product Offerings

24.24     Healgen Scientific

24.24.1  Business Overview

24.24.2  Product Offerings

24.25     Hangzhou AllTest Biotech

24.25.1  Business Overview

24.25.2  Product Offerings

24.26     Hangzhou Biotest Biotech

24.26.1  Business Overview

24.26.2  Product Offerings

24.27     Jiangsu Well Biotech

24.27.1  Business Overview

24.27.2  Product Offerings

24.28     Kabla Diagnostics

24.28.1  Business Overview

24.28.2  Product Offerings

24.29     Luminex

24.29.1  Business Overview

24.29.2  Product Offerings

24.30     Meridian Bioscience

24.30.1  Business Overview

24.30.2  Product Offerings

24.31     Megna Health

24.31.1  Business Overview

24.31.2  Product Offerings

24.32     Microgen

24.32.1  Business Overview

24.32.2  Product Offerings

24.33     MP Biomedicals

24.33.1  Business Overview

24.33.2  Product Offerings

24.34     NovaTech Immunodiagnostica

24.34.1  Business Overview

24.34.2  Product Offerings

24.35     NOWDiagnostics

24.35.1  Business Overview

24.35.2  Product Offerings

24.36     Quotient

24.36.1  Business Overview

24.36.2  Product Offerings

24.37     Qiagen

24.37.1  Business Overview

24.37.2  Product Offerings

24.38     Quidel

24.38.1  Business Overview

24.38.2  Product Offerings

24.39     Sekisui Diagnostics

24.39.1  Business Overview

24.40     Sinocare

24.40.1  Business Overview

24.40.2  Product Offerings

24.41     SureScreen Diagnostics

24.41.1  Business Overview

24.41.2  Product Offerings

24.42     Salofa Oy

24.42.1  Business Overview

24.42.2  Product Offerings

24.43     Snibe Diagnostics

24.43.1  Business Overview

24.43.2  Product Offerings

24.44     SYSMEX

24.44.1  Business Overview

24.44.2  Product Offerings

24.45     SEASUN BIOMATERIALS

24.45.1  Business Overview

24.45.2  Product Offerings

24.46     Vibrant America

24.46.1  Business Overview

24.46.2  Product Offerings

24.47     Warrior Diagnostics

24.47.1  Business Overview

24.47.2  Product Offerings

24.48     Xiamen Biotime BiotechnOlogy

24.48.1  Business Overview

24.48.2  Product Offerings

24.49     Zuhai Livzon Diagnostics

24.49.1  Business Overview

24.49.2  Product Offerings

 

25           Report Summary

25.1        Key Takeaways

25.2        Strategic Recommendations

 

26           Quantitative Summary

26.1        Market By Geography

26.2        Market By Test Type

26.3        Market By Product Type

26.4        Market By End-User

26.5        Market By Technology

 

27           Appendix

27.1        Abbreviations

               

 

               

List Of Exhibits 

Exhibit 1               Segmentation of Global Covid-19 Diagnostic Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               COVID-19 Diagnostics: Supply Chain Analysis

Exhibit 4               Impact of Demand for Mass Testing

Exhibit 5               Impact of Raise of Second Wave of Covid-19

Exhibit 6               Impact of High Demand for Molecular Diagnostics

Exhibit 7               Comparison of Regions Conducting Molecular PCR Tests & Other Tests

Exhibit 8               Impact of Unavailability of Specific Medicines/Vaccines

Exhibit 9               Comparison of the Total infectious Disease Market to Covid-19 market 2021 (billion)

Exhibit 10             Essential Role of Laboratory Diagnostics in Covid-19 Infection

Exhibit 11             Impact of More Product Launches Combined with EUA

Exhibit 12             Impact of Widespread Practice of Testing to Control COVID-19

Exhibit 13             Impact of Challenges in Testing COVID-19 in Developing Countries

Exhibit 14             Impact of Preventive Measures, Lockdown, and Fastrack of Vaccine Development

Exhibit 15             Impact of Increase in Proportion of False Positive and Negative Tests

Exhibit 16             Impact of False Positive & Negative Results For 100 samples

Exhibit 17             Global COVID-19 Diagnostics Market 2020–2026 ($ billion)

Exhibit 18             Global COVID-19 Diagnostics Market by Product

Exhibit 19             Global COVID-19 Diagnostics Market by Tests

Exhibit 20             Global COVID-19 Diagnostics Market by Technology

Exhibit 21             Global COVID-19 Diagnostics Market by End-User

Exhibit 22             Global COVID-19 Diagnostics Market by Geography

Exhibit 23             Five Forces Analysis 2020

Exhibit 24             Incremental Growth by Segment 2020 & 2026

Exhibit 25             Global COVID-19 Diagnostics Market by Product

Exhibit 26             Global COVID-19 Diagnostics Market by Product: Incremental Growth

Exhibit 27             Global COVID-19 Diagnostics Market by Product: Absolute Growth

Exhibit 28             Global COVID-19 Diagnostics Market by Consumables: Increment Growth Versus Absolute Growth

Exhibit 29             Global COVID-19 Diagnostics Market by Consumables 2020–2026 ($ billion)

Exhibit 30             Incremental Growth by Geography 2020 & 2026

Exhibit 31             Global COVID-19 Testing Market by Analyzers: Increment Growth Versus Absolute Growth

Exhibit 32             Global COVID-19 Diagnostics Market – Analyzers & Software 2020–2026 ($ billion)

Exhibit 33             Incremental Growth by Geography 2020 & 2026

Exhibit 34             Incremental Growth by Test 2020 & 2026

Exhibit 35             Global Covid-19 Diagnostics Market by Test Type

Exhibit 36             Global COVID-19 Diagnostics Market by Test Type: Incremental Growth

Exhibit 37             Global COVID-19 Diagnostics Market by Test Type: Absolute Growth

Exhibit 38             Global COVID-19 Testing Market by PCR Test: Increment Growth Versus Absolute Growth

Exhibit 39             Global COVID-19 Diagnostics – PCR Market 2020–2026 ($ billion)

Exhibit 40             Incremental Growth by Segment 2020 & 2026

Exhibit 41             GlobaTesting Market by Antigen Test: Increment Growth Versus Absolute Growth

Exhibit 42             Global COVID-19 Diagnostics – Antigen Test Market 2020–2026 ($ billion)

Exhibit 43             Incremental Growth by Geography 2020 & 2026

Exhibit 44             Global Covid-19 Testing Market by Antibody Testing: Increment Growth Versus Absolute Growth

Exhibit 45             Global COVID-19 Diagnostics Market – Antibody Testing 2020–2026 ($ billion)

Exhibit 46             Incremental Growth by Application 2020 & 2026

Exhibit 47             Incremental Growth by Technology2020 & 2026

Exhibit 48             Global Covid-19 Diagnostics Market by Technology

Exhibit 49             Global COVID-19 Diagnostics Market by Technology: Incremental Growth

Exhibit 50             Global COVID-19 Diagnostics Market by Technology: Absolute Growth

Exhibit 51             Global COVID-19 Testing Market by Molecular: Increment Growth Versus Absolute Growth

Exhibit 52             Global COVID-19 Diagnostics Market – Molecular Diagnostics 2020–2026 ($ billion)

Exhibit 53             Incremental Growth by Geography 2020 & 2026

Exhibit 54             Global COVID-19 Testing Market by Immunoassay: Increment Growth Versus Absolute Growth

Exhibit 55             Global COVID-19 Diagnostics – Immunoassay Market 2020–2026 ($ billion)

Exhibit 56             Incremental Growth by Geography 2020 & 2026

Exhibit 57             Incremental Growth by Segment 2020 & 2026

Exhibit 58             Global Infectious Diseases Diagnostics Market by Test

Exhibit 59             Global COVID-19 Diagnostics Market by End-User: Incremental Growth

Exhibit 60             Global COVID-19 Diagnostics Market by End-User: Absolute Growth

Exhibit 61             Global COVID-19 Testing Market by Diagnostic Laboratories: Increment Growth Versus Absolute Growth

Exhibit 62             Global COVID-19 Diagnostics Market – Diagnostic Laboratories 2020–2026 ($ billion)

Exhibit 63             Global Covid-19 Testing Market by Hospitals: Increment Growth Versus Absolute Growth

Exhibit 64             Global COVID-19 Diagnostics Market- Hospitals 2020–2026 ($ billion)

Exhibit 65             Global COVID-19 Testing Market by Ambulatory Care Settings: Increment Growth Versus Absolute Growth

Exhibit 66             Global COVID-19 Ambulatory Care Settings Market 2020–2026 ($ billion)

Exhibit 67             Global COVID-19 Testing Market by Research Institutes: Increment Growth Versus Absolute Growth

Exhibit 68             Global COVID-19 Diagnostics Market- Research Institutes 2020–2026 ($ billion)

Exhibit 69             Incremental Growth by Geography 2020 & 2026

Exhibit 70             Global Covid-19 Diagnostics Market by Geography

Exhibit 71             COVID-19 Diagnostics Market in APAC: Key Countries 2020 ($ billion)

Exhibit 72             COVID-19 Diagnostics Market in APAC: Incremental Growth versus Absolute Growth Comparison

Exhibit 73             COVID-19 Diagnostics Market in APAC 2020–2026 ($ billion)

Exhibit 74             Incremental Growth in APAC 2020 & 2026

Exhibit 75             COVID-19 Diagnostics Market in China 2020–2026 ($ billion)

Exhibit 76             Daily Nucleic acid Testing Capacity (In Thousands)

Exhibit 77             COVID-19 Diagnostics Market in India 2020–2026 ($ billion)

Exhibit 78             Types of Test Conducted in Japan (million)

Exhibit 79             COVID-19 Diagnostics Market in Japan 2020–2026 ($ billion)

Exhibit 80             COVID-19 Diagnostics Market in South Korea 2020–2026 ($ billion)

Exhibit 81             COVID-19 Diagnostics Market in Australia 2020–2026 ($ billion)

Exhibit 82             COVID-19 Diagnostics Market in Indonesia 2020–2026 ($ billion)

Exhibit 83             COVID-19 Diagnostics Market in Philippines 2020–2026 ($ billion)

Exhibit 84             COVID-19 Diagnostics Market in North America: Key Countries 2020 ($ billion)

Exhibit 85             COVID-19 Diagnostics Market in North America: Incremental Growth versus Absolute Growth Comparison

Exhibit 86             COVID-19 Diagnostics Market in North America 2020–2026 ($ billion)

Exhibit 87             Incremental Growth in North America 2020 & 2026

Exhibit 88             COVID-19 Diagnostics Market in US 2020–2026 ($ billion)

Exhibit 89             COVID-19 Diagnostics Market in Canada 2020–2026 ($ billion)

Exhibit 90             COVID-19 Diagnostics Market in Europe: Key Countries 2020 ($ billion)

Exhibit 91             COVID-19 Diagnostics Market in Europe: Incremental Growth versus Absolute Growth Comparison

Exhibit 92             COVID-19 Diagnostics Market in Europe 2020–2026 ($ billion)

Exhibit 93             Incremental Growth in Europe 2020 & 2026

Exhibit 94             COVID-19 Diagnostics Market in Russia 2020–2026 ($ billion)

Exhibit 95             COVID-19 Diagnostics Market in UK 2020–2026 ($ billion)

Exhibit 96             COVID-19 Diagnostics Market in Germany 2020–2026 ($ billion)

Exhibit 97             COVID-19 Diagnostics Market in Spain 2020–2026 ($ billion)

Exhibit 98             COVID-19 Diagnostics Market in France 2020–2026 ($ billion)

Exhibit 99             COVID-19 Diagnostics Market in Italy 2020–2026 ($ billion)

Exhibit 100          COVID-19 Diagnostics Market in Middle East & Africa: Key Countries 2020 ($ billion)

Exhibit 101          COVID-19 Diagnostics Market in the Middle East and Africa: Incremental Growth versus Absolute Growth Comparison

Exhibit 102          COVID-19 Diagnostics Market in Middle East & Africa 2020–2026 ($ billion)

Exhibit 103          Incremental Growth in Middle East and Africa 2020 & 2026

Exhibit 104          COVID-19 Diagnostics Market in Turkey 2020–2026 ($ billion)

Exhibit 105          COVID-19 Diagnostics Market in Saudi Arabia 2020–2026 ($ billion)

Exhibit 106          COVID-19 Diagnostics Market in South Africa 2020–2026 ($ billion)

Exhibit 107          COVID-19 Diagnostics Market in Iran 2020–2026 ($ billion)

Exhibit 108          Latin America Countries -Tests per 1000

Exhibit 109          COVID-19 Diagnostics Market in Latin America: Key Countries 2020 ($ billion

Exhibit 110          COVID-19 Diagnostics Market in Latin America: Incremental Growth versus Absolute Growth Comparison

Exhibit 111          COVID-19 Diagnostics Market in Latin America 2020–2026 ($ billion)

Exhibit 112          Incremental Growth in Latin America 2020 & 2026

Exhibit 113          COVID-19 Diagnostics Market in Brazil 2020–2026 ($ billion)

Exhibit 114          COVID-19 Diagnostics Market in Peru 2020–2026 ($ billion)

Exhibit 115          COVID-19 Diagnostics Market in Columbia 2020–2026 ($ billion)

Exhibit 116          COVID-19 Diagnostics Market in Chile 2020–2026 ($ billion)

Exhibit 117          COVID-19 Diagnostics Market in Mexico 2020–2026 ($ billion)

Exhibit 118          COVID-19 Diagnostics Market in Argentina 2020–2026 ($ billion)

Exhibit 119          Recent initiatives of ACT-Accelerator

Exhibit 120          Abbott: Sales Breakdown by Segments in 2018-19 ($ million)

Exhibit 121          Abbott: Net Sales 2017-19 ($ million)

Exhibit 122          Abbott: Net Sales Breakdown by Diagnostic Product Segment 2018-19 ($ million)

Exhibit 123          F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($billion)

Exhibit 124          F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($billion)

Exhibit 125          Thermo Fisher Scientific: Revenue 2017-2019 ($ million)

Exhibit 126          Thermo Fisher Scientific: R&D Expenditure 2017-2019 ($ million)

Exhibit 127          Thermo Fisher Scientific: Revenue by Geography 2019 (%)

Exhibit 128          Danaher: Revenue by Segment 2018 &2019 ($ million)

Exhibit 129          Danaher: Net Sales 2017-2019 ($ million)

Exhibit 130          Danaher: Revenue by Geography 2019

Exhibit 131          BD Revenue by Segment 2017- 2019 ($ million)

Exhibit 132          BD: Research& Development 2017-2019 ($ million)

               

List Of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  Commonly Used COVID-19-PCR-Based Test Kit

Table 4                  Commonly Used COVID-19 -PCR Based Test Kit

Table 5                  COVID-19 Vaccine Candidates in Phase1-3 Trials and Pre-Clinical Stages of Development and Research

Table 6                  PCR -Advantages and Disadvantages

Table 7                  Types of Serological Tests

Table 8                  WHO- COVID-19 Reference Laboratories

Table 9                  State Wise Tests Conducted

Table 10               FDA Approved Key Manufacturers of COVID-19 Diagnostic Kits for the US

Table 11               African Countries -COVID-19 Testing Data (As of (2020- August mid)

Table 12               Key Companies Response to Covid-19 Pandemic

Table 13               F. Hoffmann-La Roche COVID-19 Tests Portfolio

Table 14               Abbott: Major Product Offerings

Table 15               Siemens Healthineers: Major Product Offerings

Table 16               F. Hoffmann-LaRoche: Major Product Offerings

Table 17               Thermo Fisher Scientific: Major Product Offerings

Table 18               Danaher: Major Product Offerings

Table 19               BD: Major Product Offerings

Table 20               Abingdon Health: Major Product Offerings

Table 21               ACCESS BIO: Major Product Offerings

Table 22               Assure Tech. (Hangzhou): Major Product Offerings

Table 23               Autobio: Major Product Offerings

Table 24               Advaite: Major Product Offerings

Table 25               Babson Diagnostics: Major Product Offerings

Table 26               Beijing Wantai Biological: Major Product Offerings

Table 27               Biomerica: Major Product Offerings

Table 28               bioMérieux: Major Product Offerings

Table 29               Biopanda Reagents: Major Product Offerings

Table 30               Biocerna: Major Product Offerings

Table 31               Biocan Diagnostics: Major Product Offerings

Table 32               BioMedomics: Major Product Offerings

Table 33               Clinical Reference Laboratory: Major Product Offerings

Table 34               Cellex: Major Product Offerings

Table 35               CDC: Major Product Offerings

Table 36               CTK Biotech: Major Product Offerings

Table 37               DiaSorin: Major Product Offerings

Table 38               Diazyme Laboratories: Major Product Offerings

Table 39               Erba Mannheim: Major Product Offerings

Table 40               Edinburgh Genetics: Major Product Offerings

Table 41               Eurofins Scientific: Major Product Offerings

Table 42               GenScript: Major Product Offerings

Table 43               Healgen Scientific: Major Product Offerings

Table 44               Hangzhou AllTest Biotech: Major Product Offerings

Table 45               Hangzhou Biotest Biotech: Major Product Offerings

Table 46               Jiangsu Well Biotech: Major Product Offerings

Table 47               Kabla Diagnostics: Major Product Offerings

Table 48               Luminex: Major Product Offerings

Table 49               Meridian Bioscience: Major Product Offerings

Table 50               Megna Health: Major Product Offerings

Table 51               Microgen: Major Product Offerings

Table 52               MP Biomedicals: Major Product Offerings

Table 53               Nova Tech Immunodiagnostica: Major Product Offerings

Table 54               NOWDiagnostics: Major Product Offerings

Table 55               Quotient: Major Product Offerings

Table 56               Qiagen: Major Product Offerings

Table 57               Quidel: Major Product Offerings

Table 58               Sekisui Diagnostics: Major Product Offerings

Table 59               Sinocare: Major Product Offerings

Table 60               SureScreen Diagnostics: Major Product Offerings

Table 61               Salofy Oy: Major Product Offerings

Table 62               Snibe Diagnostics: Major Product Offerings

Table 63               Sysmex: Major Product Offerings

Table 64               SEASUN BIOMATERIALS: Major Product Offerings

Table 65               Vibrant America: Major Product Offerings

Table 66               Warrior Diagnostics: Major Product Offerings

Table 67               Xiamen Biotime Biotechnology: Major Product Offerings

Table 68               Zuhai Livzon Diagnostics: Major Product Offerings

Table 69               Global Covid-19 Diagnostics Market by Geography 2020−2026 ($ billion)

Table 70               Global Covid-19 Diagnostics Market by Geography 2020−2026 ($ billion)

Table 71               Global Covid-19 Diagnostics Market Test Type 2019−2025 ($ billion)

Table 72               Global Covid-19 Diagnostics Market by Test Type 2019−2025 (%)

Table 73               Global Covid-19 Diagnostics Market Product Type 2020−2026 ($ billion)

Table 74               Global Covid-19 Diagnostics Market by Product 2020−2026 (%)

Table 75               Global Covid-19 Diagnostics Market End-User 2020−2026 ($ billion)

Table 76               Global Covid-19 Diagnostics Market by End-User 2020−2026 (%)

Table 77               Global Covid-19 Diagnostics Market Technology 2020−2026 ($ billion)

Table 78               Global Covid-19 Diagnostics Market by Technology 2020−2026 (%)

Select a license type that suits your business needs

Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date